Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Le Guellec

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Drug Monitoring|January 22, 2002
Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detectionP Leibenguth, C Le Guellec, J M Besnier, et al.
European Journal of Clinical Pharmacology|November 27, 2002
Population pharmacokinetics of cisapride in neonatesF Odoul, C Le Guellec, A Henrot, et al.
European Journal of Clinical Pharmacology|December 25, 2004
Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patientsM Büchler, P Leibenguth, C Le Guellec, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 1999
Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary diseaseC Guerin, A Chevre, P Dessirier, et al.
La Revue De Medecine Interne|January 1, 1993
[Hemorrhagic colitis following a treatment with metacycline]C Le Guellec, B Vedrenne, P Disdier, et al.
Therapeutic Drug Monitoring|April 1, 1994
Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatographyB Lacarelle, C Le Guellec, A Morel, et al.
Therapie|January 25, 2002
Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral dosesF Odoul, C Le Guellec, C Giraut, et al.
Journal of Immunological Methods|July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serumH Blasco, G Lalmanach, E Godat, et al.
Therapeutic Drug Monitoring|May 16, 2012
New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipientsI Benz-de Bretagne, C Le Guellec, J M Halimi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Drug Monitoring|January 22, 2002
Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detectionP Leibenguth, C Le Guellec, J M Besnier, et al.
European Journal of Clinical Pharmacology|November 27, 2002
Population pharmacokinetics of cisapride in neonatesF Odoul, C Le Guellec, A Henrot, et al.
European Journal of Clinical Pharmacology|December 25, 2004
Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patientsM Büchler, P Leibenguth, C Le Guellec, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 1999
Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary diseaseC Guerin, A Chevre, P Dessirier, et al.
La Revue De Medecine Interne|January 1, 1993
[Hemorrhagic colitis following a treatment with metacycline]C Le Guellec, B Vedrenne, P Disdier, et al.
Therapeutic Drug Monitoring|April 1, 1994
Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatographyB Lacarelle, C Le Guellec, A Morel, et al.
Therapie|January 25, 2002
Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral dosesF Odoul, C Le Guellec, C Giraut, et al.
Journal of Immunological Methods|July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serumH Blasco, G Lalmanach, E Godat, et al.
Therapeutic Drug Monitoring|May 16, 2012
New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipientsI Benz-de Bretagne, C Le Guellec, J M Halimi, et al.
Pageof 3